Downloads: 131

Files in This Item:
File Description SizeFormat 
24_0541.pdf956.92 kBAdobe PDFView/Open
Title: 進行膀胱癌の化学療法
Other Titles: CHEMOTHERAPY FOR ADVANCED BLADDER CANCER
Authors: 三品, 輝男  KAKEN_name
都田, 慶一  KAKEN_name
荒木, 博孝  KAKEN_name
藤原, 光文  KAKEN_name
小林, 徳朗  KAKEN_name
渡辺, 泱  KAKEN_name
Author's alias: Mishina, Teruo
Miyakoda, Keiichi
Araki, Hirotaka
Fujiwara, Terufumi
Kobayashi, Tokuroh
Watanabe, Hiroki
Issue Date: Jul-1978
Publisher: 京都大学医学部泌尿器科学教室
Journal title: 泌尿器科紀要
Volume: 24
Issue: 7
Start page: 541
End page: 546
Abstract: 1) 1.5 g Futraful suppository was administered daily to 6 patients with advanced bladder cancer. They were 2 cases in stage B2-C and 4 cases in stage D. The total dose ranged from 40.5 to 295.5 g. OK-432 was used simultaneously in 3 patients, and OK-432 with adriamycin instillation was used in I patient. 2) According to Karnofsky's criteria, I case was judged as 1-A and 2 cases as 1-B, therefore total effective rate, was 50%. 3) Pancytopenia and stomatitis were observed in 1 case, while leukopenia in another 1 case but recovery from these side effects was achieved after the cessation of Futraful suppository with suitable treatment.
URI: http://hdl.handle.net/2433/122238
Appears in Collections:Vol.24 No.7

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.